Investigational Digestive & weight

PN-943

PN-943 is an oral α4β7 integrin antagonist peptide. It is filed in this library under digestive & weight, a navigation topic rather than a statement of where it acts. As a regulatory matter it is being studied in clinical trials and is not approved by the FDA.

Regulatory status

PN-943 is investigational.

It has not been approved by the FDA for any use.

ClinicalTrials.gov lists 1 registered study for it.

The evidence

What has actually been published

One source on PN-943, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.

Nearby

Other peptides acting on digestive & weight

Start with your own numbers.

Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.

See the OPTML Score

Educational reference only. This page explains what has been published about PN-943. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.

Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.

All 150 peptides